Miller J F, Morahan G, Slattery R, Allison J
Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria, Australia.
Immunol Rev. 1990 Dec;118:21-35. doi: 10.1111/j.1600-065x.1990.tb00812.x.
Self-tolerance is generally induced by intrathymic clonal deletion of T cells with reactivity directed to antigens synthesized within the thymus (Kappler et al. 1987, Kisielow et al. 1988). It may also be induced in peripheral T cells when these encounter antigens unique to extra-thymic tissues. Two transgenic models have been particularly useful in the study of peripheral self tolerance: in one model, a known antigen is expressed in a particular extra-thymic site; in the other, the T-cell repertoire is predominantly reactive to this antigen. We, and others, have shown that expression of class I or II MHC molecules in defined extra-thymic sites leads to a state of T-cell tolerance. To account for this, we have proposed two hypotheses which have different implications for autoimmune disease. According to one, tolerance is imposed by deletion or functional silencing of specific high-affinity cytolytic T cells; alternatively, the target cell for tolerance induction may be a regulatory IL-2-producing T-cell, rather than the effector cell itself. To distinguish between these hypotheses it is essential to examine the fate of T cells which have the potential to react to the transgene product. Since the frequency of such T cells is low and there is no dominant clonotype for H-2Kb, which is the class I molecule we used, it was necessary to create double transgenic mice by mating class I transgenic mice with transgenic mice whose T-cell pool was compared of cells reactive to H-2Kb and could be detected by an antibody directed to the TCR. Initial studies showed that such T cells did persist despite the presence of antigen to which they may be reactive. If these double transgenic mice can be shown to be tolerant, they will offer a rich source of tolerant T cells for detailed investigation of their phenotype and fate, and they will be most useful in enabling us to probe the mechanisms responsible for the induction of peripheral self tolerance. Transgenic mouse technology has also been used successfully to unravel the genetic influences which may lead to or prevent autoimmunity. In particular, we have prevented autoimmune diabetes in the nonobese diabetic mouse by introducing a non-NOD MHC class II gene and further work is implicating the failure of intrathymic positive selection of a protective cell as one step in the pathogenesis of diabetes in NOD mice.
自身耐受性通常是由胸腺内针对在胸腺中合成的抗原具有反应性的T细胞进行克隆清除所诱导的(卡普勒等人,1987年;基斯洛等人,1988年)。当外周T细胞遇到胸腺外组织特有的抗原时,也可能被诱导产生自身耐受性。两种转基因模型在研究外周自身耐受性方面特别有用:在一种模型中,一种已知抗原在特定的胸腺外位点表达;在另一种模型中,T细胞库主要对该抗原具有反应性。我们和其他人已经表明,在特定的胸腺外位点表达I类或II类MHC分子会导致T细胞耐受状态。为了解释这一点,我们提出了两种假说,它们对自身免疫性疾病有不同的影响。根据一种假说,耐受性是通过特定高亲和力细胞溶解T细胞的清除或功能沉默来施加的;或者,诱导耐受性的靶细胞可能是产生调节性白细胞介素-2的T细胞,而不是效应细胞本身。为了区分这些假说,检查有可能对转基因产物产生反应的T细胞的命运至关重要。由于此类T细胞的频率很低,而且对于我们所使用的I类分子H-2Kb没有优势克隆型,因此有必要通过将I类转基因小鼠与T细胞库由对H-2Kb有反应且可被针对TCR的抗体检测到的细胞组成的转基因小鼠交配来创建双转基因小鼠。初步研究表明,尽管存在它们可能有反应的抗原,此类T细胞确实持续存在。如果这些双转基因小鼠能够被证明具有耐受性,它们将为详细研究其表型和命运提供丰富的耐受性T细胞来源,并且在使我们能够探究负责诱导外周自身耐受性的机制方面将非常有用。转基因小鼠技术也已成功用于揭示可能导致或预防自身免疫的遗传影响。特别是,我们通过引入非NOD MHC II类基因预防了非肥胖糖尿病小鼠的自身免疫性糖尿病,并且进一步的研究表明,在NOD小鼠糖尿病发病机制的一个步骤中,胸腺内保护性细胞的阳性选择失败。